Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series
-
* Corresponding author: Carsten Saft carsten.saft@ruhr-uni-bochum.de
BMC Neurology 2006, 6:11 doi:10.1186/1471-2377-6-11
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 21 Jul 2005 | |
| Resubmission - Version 2 | Manuscript | 25 Aug 2005 | |
| Reviewer's Report | Raphael Bonelli | 23 Oct 2005 | |
| Reviewer's Report | Steven Frucht | 07 Nov 2005 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 29 Nov 2005 |
| Reviewer's Report | Raphael Bonelli | 16 Dec 2005 | |
| Reviewer's Report | Steven Frucht | 10 Jan 2006 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 06 Feb 2006 |
| Published | 28 Feb 2006 |